Differential pricing is necessary to provide suffering people in poor countries access to needed medicines and ensure that medical innovation will continue in the future.

Counterfeit and substandard medicines are a huge roadblock for global health, so why do large NGOs not do more to stop them?

The West African nation, which turns fifty today, has managed to pull democracy and growth out of the most challenging circumstances.

Funding for malaria control has increased significantly over the past decade, but it is still unclear whether that funding is actually saving lives.

The Global Fund to Fight AIDS, Tuberculosis, and Malaria will only be as effective as its procurement process allows.

Efforts to improve global health are often crippled by a state of denial.

Given the poor track record of foreign aid in developing countries, simply sending more aid would be counterproductive unless drastic changes are made.

To make essential drugs available to needy patients in poor countries, those countries need to take down their trade barriers.